Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

SOPHiA GENETICS (SOPH) Enterprise Value (2020 - 2025)

Historic Enterprise Value for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to -$81.6 million.

  • SOPHiA GENETICS's Enterprise Value rose 1480.05% to -$81.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$81.6 million, marking a year-over-year increase of 1480.05%. This contributed to the annual value of -$123.3 million for FY2024, which is 2359.13% up from last year.
  • SOPHiA GENETICS's Enterprise Value amounted to -$81.6 million in Q3 2025, which was up 1480.05% from -$94.8 million recorded in Q2 2025.
  • SOPHiA GENETICS's Enterprise Value's 5-year high stood at -$57.1 million during Q1 2021, with a 5-year trough of -$280.6 million in Q3 2021.
  • Over the past 5 years, SOPHiA GENETICS's median Enterprise Value value was -$132.8 million (recorded in 2023), while the average stood at -$145.3 million.
  • Its Enterprise Value has fluctuated over the past 5 years, first plummeted by 32638.1% in 2022, then surged by 5026.44% in 2024.
  • Quarter analysis of 5 years shows SOPHiA GENETICS's Enterprise Value stood at -$265.3 million in 2021, then grew by 20.75% to -$210.3 million in 2022, then rose by 23.29% to -$161.3 million in 2023, then skyrocketed by 50.26% to -$80.2 million in 2024, then fell by 1.73% to -$81.6 million in 2025.
  • Its Enterprise Value was -$81.6 million in Q3 2025, compared to -$94.8 million in Q2 2025 and -$68.5 million in Q1 2025.